PROVIDER PROFILE · NPI 1215901426

Anardi Agosto-Mujica

Allergy/ ImmunologyCayey, PRI

MEDICARE UTILIZATION · PART B · 2024

No data available for this provider in 2024.

PRESCRIBING · PART D · 2024

Total Rx claims

3,621

Beneficiaries

—

Total drug cost

$2.1M

Distinct drugs

Brand share

27.0%

Top prescribed drugs

Fluticasone Propionate672 claims

Montelukast Sodium573 claims

Fluticasone/Umeclidin/Vilanter275 claims

Azelastine Hcl259 claims

Famotidine247 claims

QUALITY · MIPS · 2024

No data available for this provider in 2024.

INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024

Total received

$29K

Payment records

By payment type

Consulting Fee$25K

Travel and Lodging$3K

Food and Beverage$2K

Education$15

REFERRAL NETWORK

Where Anardi Agosto-Mujica's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 0 inbound referrers · 3 outbound destinations.

Receives referrals from

Inbound — who sends patients here

No inbound pairs above the suppression threshold.

Refers patients to

Outbound — where patients go next

Physician	Patients	Visits
HOSPITAL MENONITA DE CAYEY	18	49
Marielba Agosto Endocrinology · Cayey, PR	15	35
Silverio Perez Diagnostic Radiology · Cayey, PR	11	19

Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.

CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore

OIG/SAM exclusion screening, sanctions history